Sunny Reddy

Sunny Reddy has made 60 investments in companies such as: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals, Asensus Surgical, Esperion Therapeutics, F2G, T2 Biosystems, Eidos Therapeutics, Versartis, TRIA Beauty, Nuvation Bio, Xanodyne, Seragon Pharmaceuticals, Spirox, Verona Pharma, Avrobio, Talaris Therapeutics, Bioenvision, Miramar Labs, GTx, Sirion Therapeutics, Cempra, Ambit Biosciences, CeNeRx BioPharma, BridgeBio, NextWave Pharmaceuticals, Pharmaron Holding, Topaz Pharmaceuticals Inc, Loxo Oncology, Elevation Oncology, Bridge Pharmaceuticals, Natural Dentist, Reneo Pharmaceuticals, Atreca, Aclaris Therapeutics, Promentis Pharmaceuticals, Agile Therapeutics, Biohaven Pharmaceutical, BioRelix, Cytos, Biomea Fusion, Ajax Health, Monte Rosa Therapeutics, ViewRay, Poseida Therapeutics, PowerVision, Cynapsus Therapeutics, VYNE Therapeutics, Cidara Therapeutics, Paratek Pharmaceuticals, Bristol-Myers Squibb, Aimmune Therapeutics, LensAR, Earlens Corporation, Arcus Biosciences, Roka Bioscience, ObsEva, Aragon Pharmaceuticals, Prolacta Bioscience.

Location of Sunny Reddy is United States.

The free version of Angel Match provides limited data for Sunny Reddy. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.

Sunny Reddy is a Analyst and he his investment types are: Private Equity Firm.
Sunny Reddy focuses investing in industries such as: Biopharma, Biotechnology, Therapeutics, Medical, Life Science, Pharmaceutical, Health Care, Women Founded, Women Led.

A short brief about investor:


Past investments

Social media:

Available after registration.